Both in Pharmaceuticals
RenovoRx vs Citius Oncology
Over the past year RNXT returned +18.3% and CTOR returned −67.7%; their daily moves had a correlation of 0.13.
RNXT +18.3% CTOR −67.7%Growth of $1, one year, split-adjusted
| Metric | RNXT | CTOR |
|---|---|---|
| Price | $1.29 | $0.5401 |
| Market cap | $58.2M | $57.1M |
| Today | 0.00% | −1.80% |
| 1 month | −7.2% | −36.5% |
| 6 months | +45.0% | −40.6% |
| Year to date | +53.6% | −46.0% |
| 1 year | +18.3% | −67.7% |
| Revenue growth (YoY) | +115.4% | — |
| Gross margin | 84.3% | 67.1% |
| Net margin | −320.2% | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | 29.5× | 8.0× |
| Net cash | $9.5M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 108.3% | 99.0% |
| Short % of float | 2.0% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).